To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
NCT00881179 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-03-28
Summary
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
Conditions
- Healthy
Interventions
- DRUG
-
Clarithromycin 250 mg Tablets (Geneva Pharmaceuticals, USA)
- DRUG
-
Biaxin (Clarithromycin) 250 mg Tablets (Abbott Laboratories, Inc, USA)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
So Ran Hong, M.D. · Novum Pharmaceutical Research Services
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-05-31
- Primary Completion
- 2002-06-30
- Completion
- 2002-06-30
More Related Trials
-
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
NCT00840216 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir
NCT02251769 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects
NCT02227030 ·Status: COMPLETED ·Phase: PHASE1
-
Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions
NCT00836056 ·Status: COMPLETED ·Phase: PHASE1
-
Study of BIIB091 Formulations in Healthy Participants
NCT04564612 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Klaribact 125mg/5ml, Suspension
NCT05340452 ·Status: COMPLETED ·Phase: NA
-
Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers
NCT02172209 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions
NCT00866216 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects
NCT02175238 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
NCT02268604 ·Status: TERMINATED ·Phase: PHASE1
-
Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects
NCT02264197 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Subjects
NCT00924911 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.
NCT00881153 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants
NCT05271799 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers
NCT02253953 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers
NCT02171754 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects
NCT02223000 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers
NCT02211937 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
NCT01648179 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants
NCT06988423 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
NCT00865670 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers
NCT02161432 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.
NCT02853435 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers
NCT02215759 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers
NCT02183623 ·Status: COMPLETED ·Phase: PHASE1